Dysautonomia, Autoimmune/Paraneoplastic Evaluation

Synonyms

  • DYS2
  • DYSAUTONOMIA AUTOIMMUNE/PARANEO EVAL
  • LAB4211

Cerner Name

Dysautonomia Autoimmune/Paraneo Eval

Clinical Info

Investigating autonomic symptoms that appear in the course or wake of cancer therapy and are not explainable by recurrent cancer or metastasis 
(detection of autoantibodies in this profile helps differentiate autoimmune dysautonomia from the effects of chemotherapy)

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Specimen Volume

Container

Container: Red top Tube preferred
                  Gold top Tube acceptable

Collection Instructions

Container: Red top Tube or Gold top tube
Specimen Volume: 4.0 mL Serum (2.5 Min Volume)

Transport Instructions

Refrigerated Temperature

Specimen Stability

Refrigerated (preferred) 28 days
Ambient 72 hours
Frozen 28 days

Methodology

Indirect immunofluorescence assay (IFA), Cell Binding Assay, Radioimmunoassay, Immunoblot, Western Blot

Days Performed

TAT: 9-13 Days

Performing Laboratories

Mayo Medical Laboratories

CPT


83519

86255 x 7

PDM

255267

Results
Component Name Base Name Common Name External Name
DYSAUTONOMIA INTERPRETATION, S DYS2X DYSAUTONOMIA INTERPRETATION, S Dysautonomia Interpretation, S
IFA NOTES IFANOTES IFA NOTES IFA Notes
REFLEX ACHR GANGLIONIC NEURONAL AB REFAGNAB REFLEX ACHR GANGLIONIC NEURONAL AB AChR Ganglionic Neuronal Ab, S
ANNA-1, S ANNA1S ANNA 1 S ANNA-1, S
AP3B2 IFA, S AP3B2IFAS AP3B2 IFA, S AP3B2 IFA, S
CRMP-5-IGG WESTERN BLOT CR5IGWESBLOT CR 5 IGG WES BLOT CRMP-5-IgG, S
CASPR2-IGG CBA, S CASPR2IGCBAS CASPR2 IGG CBA S CASPR2-IgG CBA, S
DPPX AB CBA, S DPPXABCBAS DPPX AB CBA, S DPPX Ab CBA, S
LGI1-IGG CBA, S LGI1IGGCBAS LGGI1 IGG CBA S LGI1-IgG CBA, S
PCA-2, S PCA2S PCA 2 S PCA-2, S

Result Interpretation

Forms
Immunology LAB4211 build edit